Product logo
  • Home
  • Sign Up
Product logo

Brooks Laboratories Ltd

News

Switch to
More ontickertape logoapp
    Home
    Sign Up

    Brooks Laboratories Ltd

    BROOKS
    95.954.50 (-4.48%)
    Investment Checklist
    BasicPro

    Intrinsic value
    Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

    Insufficient Data

    ROE vs FD rates
    Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

    Stock has not been able to generate better return on equity than bank FD

    Dividend Returns
    A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

    Stock doesn't offer attractive dividend returns

    Entry point
    High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

    Good time to consider, as stock is not in overbought zone

    No Red Flags
    ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks

    Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

    Loading...
    Go pro! Unlock deeper insights
    Get your Zerodha accountOpen Now
    OverviewForecastsFinancialsPeersHoldingsNewsEvents
    725

    News & Opinions

    725
    Articles & Videos
    News Thumbnail

    Brooks Laboratories reports consolidated net loss of Rs 4.68 crore in the September 2022 quarter

    2 months ago•Business Standard

    News Thumbnail

    Capital Trust Ltd leads gainers in ‘B’ group

    9 months ago•Business Standard

    News Thumbnail

    Brooks Laboratories’ subsidiary gets marketing authorization in Germany for Meropenem

    1 year ago•India Infoline

    News Thumbnail

    Raj Oil Mills Ltd leads gainers in ‘B’ group

    1 year ago•Business Standard

    News Thumbnail

    Gyscoal Alloys Ltd leads losers in ‘B’ group

    1 year ago•Business Standard

    News Thumbnail

    Brooks Laboratories to make new investments in JV to build integrated global carbapenem biz

    1 year ago•India Infoline

    News Thumbnail

    Brooks Laboratories reports standalone net loss of Rs 3.12 crore in the December 2020 quarter

    1 year ago•Business Standard

    © Powered byTickertape.ViewBROOKSon 

    EmailHelpBlog

    NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

    Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
    Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019